Rafael Holdings, Inc. - Dec 23, 2024 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: 10%+ Owner
Signature: /s/ William Conkling, CEO
Stock symbol: CYTH
Transactions as of: Dec 23, 2024
Transactions value $: $2,500,000
Form type: 4
Date filed: 1/13/2025, 12:29 PM
Previous filing: Oct 23, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Conversion of derivative security	$2.5M	+3.97M	+43.95%	$0.63	13M	Dec 23, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 23, 2024, the reporting person gave notice to the issuer that it had elected to convert $2,500,000 of the outstanding balance of the Convertible Promissory Note, dated August 21, 2024, made by the issuer in favor of the reporting person, into 3,968,254 shares of the issuer's common stock, at a conversion price of $0.63. The conversion price was based on the closing price of the issuer's common stock on The Nasdaq Capital Market on December 20, 2024, the trading date immediately preceding the date of conversion.

Content

On December 23, 2024, the reporting person gave notice to the issuer that it had elected to convert $2,500,000 of the outstanding balance of the Convertible Promissory Note, dated August 21, 2024, made by the issuer in favor of the reporting person, into 3,968,254 shares of the issuer's common stock, at a conversion price of $0.63. The conversion price was based on the closing price of the issuer's common stock on The Nasdaq Capital Market on December 20, 2024, the trading date immediately preceding the date of conversion.